Comparative Pharmacology
Head-to-head clinical analysis: CHILDREN S MOTRIN COLD versus PHERAZINE VC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHILDREN S MOTRIN COLD versus PHERAZINE VC.
CHILDREN'S MOTRIN COLD vs PHERAZINE VC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis. It provides analgesic, antipyretic, and anti-inflammatory effects. Pseudoephedrine is a sympathomimetic amine that directly stimulates alpha-adrenergic receptors in the respiratory tract mucosa, causing vasoconstriction and reducing nasal congestion.
Phenylephrine is a selective alpha-1 adrenergic receptor agonist causing vasoconstriction; chlorpheniramine is a first-generation antihistamine that antagonizes histamine H1 receptors; promethazine is a phenothiazine derivative with antihistamine, sedative, antiemetic, and anticholinergic effects.
Adults and children ≥12 years: 20 mL (400 mg ibuprofen/30 mg pseudoephedrine) orally every 4-6 hours as needed; maximum 80 mL (1600 mg ibuprofen/120 mg pseudoephedrine) per day.
10 mg orally every 6 hours as needed; maximum 60 mg per day.
None Documented
None Documented
Ibuprofen: 2-4 hours in children; pseudoephedrine: 5-8 hours (prolonged in alkaline urine). Clinical context: dosing intervals q6-8h for ibuprofen; pseudoephedrine accumulation possible with renal impairment.
Terminal elimination half-life is approximately 9-16 hours; clinical context: steady-state achieved in 2-3 days.
Renal: ibuprofen ~90% as metabolites and conjugates, <10% unchanged; pseudoephedrine ~70-90% unchanged renally; urinary pH influences pseudoephedrine elimination (acidic urine increases excretion). Fecal: negligible.
Primarily renal as metabolites and unchanged drug; about 70% excreted in urine, 20% in feces via biliary elimination.
Category C
Category C
Cold Combination
Cough and Cold Combination